
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $211.3M | -- | -- | $0.37 | -- |
08/04/2025 | Q2 | $215.5M | -- | -- | $0.38 | -- |
05/05/2025 | Q1 | $223.8M | $86.7M | $0.30 | $0.41 | -$0.11 |
02/04/2025 | Q4 | $226.6M | $118.8M | $0.42 | $0.43 | -$0.01 |
11/19/2024 | Q3 | $234M | $94.2M | $0.36 | $0.44 | -$0.08 |
08/05/2024 | Q2 | $189.5M | $947K | $0.05 | $0.48 | -$0.43 |
05/06/2024 | Q1 | $162.8M | $95M | $0.55 | $0.51 | $0.04 |
02/05/2024 | Q4 | $161M | $82.3M | $0.45 | $0.48 | -$0.03 |
11/20/2023 | Q3 | -- | -- | $0.60 | $0.46 | $0.14 |
08/07/2023 | Q2 | -- | -- | $0.43 | $0.42 | $0.01 |
05/08/2023 | Q1 | -- | -- | $0.34 | $0.41 | -$0.07 |
02/08/2023 | Q4 | -- | -- | $0.15 | $0.36 | -$0.21 |
11/21/2022 | Q3 | -- | -- | $0.05 | $0.30 | -$0.25 |
08/09/2022 | Q2 | -- | -- | $0.09 | $0.30 | -$0.21 |
05/10/2022 | Q1 | -- | -- | $0.39 | $0.30 | $0.10 |
02/09/2022 | Q4 | -- | -- | $0.37 | $0.29 | $0.08 |
11/29/2021 | Q3 | -- | -- | $0.42 | $0.28 | $0.14 |
08/09/2021 | Q2 | -- | -- | $0.49 | $0.30 | $0.20 |
05/10/2021 | Q1 | -- | -- | $0.55 | $0.29 | $0.26 |
02/08/2021 | Q4 | -- | -- | $0.56 | $0.28 | $0.28 |
12/01/2020 | Q3 | -- | -- | $0.57 | $0.27 | $0.30 |
08/10/2020 | Q2 | -- | -- | $0.93 | $0.27 | $0.66 |
05/11/2020 | Q1 | -- | -- | -$1.62 | $0.33 | -$1.95 |
02/10/2020 | Q4 | -- | -- | $0.34 | $0.32 | $0.02 |
11/25/2019 | Q3 | -- | -- | -$0.97 | $0.33 | -$1.29 |
08/07/2019 | Q2 | -- | -- | $0.31 | $0.32 | -$0.01 |
05/08/2019 | Q1 | -- | -- | $0.27 | $0.32 | -$0.05 |
02/06/2019 | Q4 | -- | -- | $0.29 | -- | -- |
11/28/2018 | Q3 | -- | -- | $0.28 | -- | -- |
08/08/2018 | Q2 | -- | -- | $0.34 | -- | -- |
05/07/2018 | Q1 | -- | -- | $0.37 | -- | -- |
02/08/2018 | Q4 | -- | -- | $0.34 | -- | -- |
11/21/2017 | Q3 | -- | -- | $0.36 | -- | -- |
08/07/2017 | Q2 | -- | -- | $0.33 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.36 | -- | -- |
02/09/2017 | Q4 | -- | -- | $0.32 | -- | -- |
11/17/2016 | Q3 | -- | -- | $0.28 | -- | -- |
08/03/2016 | Q2 | -- | -- | $0.33 | -- | -- |
05/05/2016 | Q1 | -- | -- | $0.27 | -- | -- |
02/05/2016 | Q4 | -- | -- | $0.38 | -- | -- |
11/17/2015 | Q3 | -- | -- | $0.36 | -- | -- |
Golub Capital BDC reported $86.7M worth of top line sales in its most recent quarter.
Golub Capital BDC announced earnings per share of $0.30 which represents a miss of analyst forecast a $0.41 per share.
Golub Capital BDC reported -- that represents -- per share over the last quarter.
Golub Capital BDC's earnings are forecast to grow from $1.36 per share to $1.92 per share next year representing an increase of 10.29%.
Golub Capital BDC's next earnings date is August 4, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.